ALLERMI
Live / Registered — Registered (as of 05 Nov 2024)
What this means for you
Registered since 05 Nov 2024. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97843222
- Registration number
- 7560594
- Mark type
- Stylized text
- Filed
- 16 Mar 2023
- Published for opposition
- 12 Mar 2024
- Registered
- 05 Nov 2024
- Attorney of record
- Dax Alvarez
Goods and services
- Class 005 — Pharmaceuticals: Allergy medications for human use; nasal spray preparations for human use
Owner
- Allermi, Inc., San Francisco, CA, US
- Allermi, Inc., San Francisco, CA, US
- Allermi, Inc., San Francisco, CA, US
Prosecution history
- 05 Nov 2024 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 05 Nov 2024 — REGISTERED-PRINCIPAL REGISTER
- 03 Oct 2024 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 03 Oct 2024 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 31 Aug 2024 — STATEMENT OF USE PROCESSING COMPLETE
- 02 Jul 2024 — USE AMENDMENT FILED
- 31 Aug 2024 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 02 Jul 2024 — TEAS STATEMENT OF USE RECEIVED
- 02 Jul 2024 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 03 Jun 2024 — POST PUBLICATION AMENDMENT - ENTERED
- 03 Jun 2024 — ASSIGNED TO PETITION STAFF
- 22 May 2024 — EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
- 16 Apr 2024 — TEAS POST PUBLICATION AMENDMENT RECEIVED
- 11 Apr 2024 — EXTENSION OF TIME TO OPPOSE RECEIVED
- 12 Mar 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED